BioSpace News Archive

Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (“Company,” “Kane Biotech”) today announced that it has entered into an agreement with Harbor Access LLC (“Harbor Access”), an investor relations advisory firm with offices in Canada and the United States. Harbor Access will provide external Investor Relations services to Kane Biotech in addition to investor outreach throughout North America and Europe. The initial term of the contract will be f

Ocutrx Vision Technologies, LLC, an augmented/extended reality manufacturing company, announced today the issuance of its third and fourth awarded patents by the U.S. Patent & Trademark Office.

Further expands Company’s patent portfolio in pursuit of worldwide intellectual property protection for Primer-Switch technology; Applicable to Coronavirus (COVID-19) Molecular Diagnostic Testing

entrinsic bioscience (EBS), a company pioneering a next generation protein modulation technology, today announced that its co-founder, Dr. Sadasivan (Sagar) Vidyasagar, an Associate Professor at University of Florida (UF), and entrinsic bioscience’s Chief Executive Officer, Stephen Gatto, received the “Invention of the Year 2020" Award f

Publication in BMC Medicine demonstrates the combination of SeptiCyte® TRIAGE and SeptiCyte® VIRUS can discriminate between bacterial and viral infections in Emergency Department patients [23-September-2020] SEATTLE , Sept. 23, 2020 /PRNewswire/ -- Immunexpress, Inc., a molecular diagnostic company focused on improving outcomes for suspected sepsis patients, announced

CapsoVision, an innovator in the gastroenterology diagnostics market, today announced that the U.S Food & Drug Administration (FDA) will apply enforcement discretion which allows at-home administration of the CapsoCam Plus ® small bowel capsule endoscope during the COVID-19 pandemic for patients who are determined eligibl

Move Reinforces NantHealth’s Commitment to Improved Connectivity For Payers, Providers, and Revenue Cycle Organizations

CBSET Inc., a not-for-profit translational research institute, announced today that the company and its partner, CILcare, a leading CRO specializing in hearing disorders, have been nominated to receive a prestigious Prix Galien Medstartup award for their collaboration in fighting hearing loss; the collaborators are nominated in the category ‘Best Collaboration Dedicated to the Developing or Underserved Populations Worldwide.’

Pear Therapeutics Announces Availability of reSET ® and reSET-O ® to Wellpath Community Care Center Patients; Wellpath to Bring Prescription Digital Therapeutics for Addiction to New Outpatient Treatment Centers Pear’s reSET and reSET-O are the first US FDA-authorized Prescription Digital Therapeutics (PDTs) for patients with substance use disorder and opioid use disorder Collaboration combines PDTs with outpatient treatment for addiction to elevat

Evotec licenses second novel polycystic ovary syndrome target identified by Celmatix through its Reproductive Atlas™ platform to Bayer AG